| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.02 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |